The Next Palantir Moment Could Be Here

A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.

TAK
Takeda Pharmaceutical Co ADR
NYSE
15.1
Open 15.11 Prev Close 15.06
High 15.18 Low 15.10
Volume 57 Volume (Avg) 3,698
52 Week High 15.69 52 Week Low 12.51
Market Cap 47.2B PE Ratio 51.07

Shares Stats

Shares Outstanding3,124,000,000
Shares Float3,124,000,000
Shares Short7,690,000
Insider Holdings1%
Institution Holdings2.51%

About Takeda Pharmaceutical Co ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.

General

NameTakeda Pharmaceutical Co ADR
TickerTAK
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyUSD
CountryUSA
Fiscal Year EndMarch
Full Time Employees47,455

Highlights

Analyst Target17.24
Market Cap47,172,400,000
PE Ratio51.07
PEG Ratio0.44
EBITDA1,219,014,950,912

Financials

Profit Margin3.19%
Operating Margin12.76
Return on Assets0.02
Return on Equity0.02
Revenue30B
Earnings Per Share0.29
Revenue Per Share1,419.75
Gross Profit2,911,105,974,272
Quarterly Revenue Growth-0.08

Valuation

Trailing PE51.93
Forward PE14.84
Price/Sales (Trailing 12 Mt.)0.01
Price/Book (Most Recent Quarter)1.02

Dividend

Takeda Pharmaceutical Co ADR pays out a dividend of $0.67 per share, with a dividend yield of 4.46%.

TAK's last dividend payment was made to shareholders on July 7, 2025.

They pay out 242.25% of their earnings out as a dividend.

Recent Dividends

Jul 7, 2025$0.34
Dec 12, 2024$0.33
Jul 8, 2024$0.30
Dec 11, 2023$0.32
Most Popular

Bill Ackman Has 70% Of His Portfolio Invested In These 5 Stocks: Here's What Q2 13F Filings Show

Discover how Bill Ackman invested ~70% of his $13.7M portfolio in 5 stocks like UBER & AMZN per Q2 2025 13F filings. Explore top holdings now!

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.

780,000 pressure washers are under recall after some consumers report explosions and impact injuries

NEW YORK (AP) — About 780,000 pressure washers sold at retailers like Home Depot are being recalled across the U.S. and Canada, due to a projectile hazard that has resulted in fractures and other injuries among some consumers.

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Powerball jackpot rises to an estimated $1.3 billion after no winning ticket sold

DES MOINES, Iowa (AP) — The Powerball jackpot rose to an estimated $1.3 billion Monday night after the winning numbers failed to appear.

Powerball Jackpot Soars To $1.1 Billion After No Winning Tickets, 5th Largest In History

The Powerball jackpot has reached $1.1 billion after no winner in Saturday's drawing, with nine tickets earning $1 million.

Scarcity Meets Momentum - Ad

With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.

Inside Warren Buffett's Decision to Keep Leading Berkshire Hathaway in His 90s

Warren Buffett's retirement decision has sparked debates about his reasons for working past the typical retirement age and his current choice to step aside.

Jim Cramer: Sell Chime, Get This Buy Now Pay Later Stock Instead

Chime Financial, on Aug. 22, announced a strategic partnership with Workday to advance financial wellness in the workplace.

Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad

Gold has hit all-time highs, breaking $3,600 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

A preliminary report on Lisbon's streetcar tragedy is expected Friday

LISBON, Portugal (AP) — Details started to emerge about the people who were killed when a derailed, as the first investigative report examining what caused the popular Lisbon tourist attraction to crash was expected to be released Friday.

Bitcoin Will Correct Further In September, Analyst Maintains

Prominent crypto analyst Benjamin Cowen has emphasized his expectation of a September pullback for Bitcoin (CRYPTO: BTC), highlighting critical support levels to watch.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Nio Lifts Deliveries Outlook As CEO Hints At SUV Market Shakeup

Nio shares traded lower after reporting Q2 results, but have since rebounded and are now up 1.72%. Revenue was $2.65B, up 9% YoY and 58% sequentially.

Jim Cramer Expects Palantir To Reach New All-Time High

Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKTX, but expects PLTR to go up.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Marriott, Toast, KeyCorp And More On CNBC's 'Final Trades'

Marriott International, which is down around 4% year-to-date, is Jenny Van Leeuwen Harrington's final trade.

More than 60 containers fall off ship in Long Beach port

LOS ANGELES (AP) — More than 60 containers toppled off a cargo ship Tuesday morning in the Port of Long Beach, tumbling overboard and floating in the water.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Bitcoin, Dogecoin, XRP Gain; Ethereum Trades Flat: Analyst Predicts ETH Reversal Before Q4 Parabolic Rally

Leading cryptocurrencies rose in tandem with stocks on Monday, as investors increased their risk appetite ahead of key inflation data reports.

'Make Cracker Barrel Great Again': Donald Trump, Republican Party Weigh In On Restaurant Logo Rebrand

A logo rebrand by Cracker Barrel may divide the nation with conservatives ready to boycott the restaurant. President Trump shares his advice.

The $25M Contract Nobody Is Talking About - Ad

One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.

Tucker Carlson Asks OpenAI CEO Sam Altman If He Ordered Employee's Murder

During an interview with OpenAI CEO Sam Altman, Tucker Carlson suggested Altman may have played a role in the death of former employee Suchir Balaji.

US media quickly forced to revisit a thorny question: How should a president's health be covered?

Early in Donald Trump's Tuesday, Fox News' Peter Doocy asked a question that surely baffled people who avoided social media for Labor Day.

This Gold Miner Has the Map, the Metal, and the Momentum - Ad

JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.

Tesla China Sales Fall 10% To 57,152 Units In August, Marking 6th Decline In 2025

Tesla sales in China fell 9.93% in August amid lackluster global sales and Model Y L receiving 120,000 orders in China.

Eightco, Nebius, Quantumscape, Planet Labs And Globalstar: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average up 0.25% at 45,514.95, the S&P 500 advancing 0.2% to 6,495.15, and the Nasdaq climbing 0.45% to 21,798.69. These are the top stocks that gained the attention of retail traders and investors throughout the day.

The Next Palantir Moment Could Be Here - Ad

A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.

Opendoor's New CEO Could Spark 'Bigger Pivot'—Analyst Sees Bottom-Line Boost

Opendoor stock is soaring after a new CEO was announced and two co-founders are rejoining the company. Here's what one analyst has to say.

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.

Someone could win $1.8B Powerball jackpot Saturday. Odds are their identity will remain a mystery

After Iowa gas station employee Timothy Schultz won a $29 million lottery jackpot in 1999, he decided to hold a press conference. Lottery officials told him it would help him avoid being “hounded by media" since state law required his name to be disclosed anyway.

Mark Cuban Once Dubbed Dogecoin 'Real Money,' While Kevin O'Leary Brushed It Off As 'Gambling' — Whose Advice Would Have Netted You More Profit

Mark Cuban and Kevin O’Leary, both prominent panelists on the reality TV show "Shark Tank," have been close friends for a long time, yet their opinions on the meme cryptocurrency Dogecoin (CRYPTO: DOGE) have yet to align.

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Trump's plan for a drug advertising crackdown faces many hurdles

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.

Israel launches a satellite to expand its surveillance capability throughout Middle East

JERUSALEM (AP) — Israel has launched a new spy satellite that defense officials described as a strategic cornerstone, saying it will strengthen their surveillance capacity across the Middle East in the years ahead.

Scarcity Meets Momentum - Ad

With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service